Abstract
Objective: Diagnostic/therapeutic accidents Background: Rituximab is a genetically engineered chimeric (murine-human) monoclonal antibody (mAb) direct......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
